{"id":2367,"date":"2015-06-18T14:44:37","date_gmt":"2015-06-18T14:44:37","guid":{"rendered":"http:\/\/blogs.sld.cu\/oserranob\/?p=2367"},"modified":"2015-06-18T16:10:20","modified_gmt":"2015-06-18T16:10:20","slug":"datos-de-farmacogenetica-en-medicamentos-europeos","status":"publish","type":"post","link":"https:\/\/blogs.sld.cu\/oserranob\/2015\/06\/18\/datos-de-farmacogenetica-en-medicamentos-europeos\/","title":{"rendered":"Datos de farmacogen\u00e9tica en medicamentos europeos"},"content":{"rendered":"<p style=\"text-align: justify\"><a href=\"https:\/\/blogs.sld.cu\/oserranob\/files\/2015\/06\/EMEA.jpg\"><img loading=\"lazy\" class=\"alignleft size-full wp-image-2381\" style=\"border-width: 1px;margin: 5px\" src=\"https:\/\/blogs.sld.cu\/oserranob\/files\/2015\/06\/EMEA.jpg\" alt=\"EMEA\" width=\"94\" height=\"91\" \/><\/a>La <a title=\"Sitio de EMA\" href=\"http:\/\/www.ema.europa.eu\/ema\/\" target=\"_blank\">Agencia Europea de Medicamentos<\/a> se ha pronunciado por refinar la regulaci\u00f3n sobre c\u00f3mo debe emplearse la informaci\u00f3n relativa a la farmacogen\u00e9tica de los 517 productos medicinales aprobados en esa regi\u00f3n para mejorar sus usos terap\u00e9uticos. La revisi\u00f3n realizada al respecto puede ser consultada en Ehmann F, Caneva L, Prasad K, Paulmich M, Maliepaard M, Llerena A, <em>et al<\/em>. <a title=\"Texto completo en ingl\u00e9s\" href=\"http:\/\/www.nature.com\/tpj\/journal\/v15\/n3\/full\/tpj201486a.html\" target=\"_blank\">Pharmacogenomic information in drug labels: European Medicines Agency perspective<\/a>. The Pharmacogenomics Journal 2015;15:201\u2013210.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>La Agencia Europea de Medicamentos se ha pronunciado por refinar la regulaci\u00f3n sobre c\u00f3mo debe emplearse la informaci\u00f3n relativa a la farmacogen\u00e9tica de los 517 productos medicinales aprobados en esa regi\u00f3n para mejorar sus usos terap\u00e9uticos. La revisi\u00f3n realizada al respecto puede ser consultada en Ehmann F, Caneva L, Prasad K, Paulmich M, Maliepaard M, [&hellip;]<\/p>\n","protected":false},"author":125,"featured_media":0,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":[],"categories":[37,15,19,23,32],"tags":[],"_links":{"self":[{"href":"https:\/\/blogs.sld.cu\/oserranob\/wp-json\/wp\/v2\/posts\/2367"}],"collection":[{"href":"https:\/\/blogs.sld.cu\/oserranob\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/blogs.sld.cu\/oserranob\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/blogs.sld.cu\/oserranob\/wp-json\/wp\/v2\/users\/125"}],"replies":[{"embeddable":true,"href":"https:\/\/blogs.sld.cu\/oserranob\/wp-json\/wp\/v2\/comments?post=2367"}],"version-history":[{"count":3,"href":"https:\/\/blogs.sld.cu\/oserranob\/wp-json\/wp\/v2\/posts\/2367\/revisions"}],"predecessor-version":[{"id":2384,"href":"https:\/\/blogs.sld.cu\/oserranob\/wp-json\/wp\/v2\/posts\/2367\/revisions\/2384"}],"wp:attachment":[{"href":"https:\/\/blogs.sld.cu\/oserranob\/wp-json\/wp\/v2\/media?parent=2367"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/blogs.sld.cu\/oserranob\/wp-json\/wp\/v2\/categories?post=2367"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/blogs.sld.cu\/oserranob\/wp-json\/wp\/v2\/tags?post=2367"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}